April 26, 2019 The FDA has approved Eticovo (etanercept-ykro), a biosimilar to U.S.-licensed Enbrel (etanercept). A biosimilar product is a biological product that is approved based on a showing that it is highly similar to an already-FDA approved…Original Article
You may also like
Dupixent (dupilumab) Approved in the U.S. as the First...
U.S. Food and Drug Administration Updates Camzyos...
FDA Grants Isturisa (osilodrostat) Expanded Indication...
Neurelis Announces FDA Approval for Immediate Use...
Mirum’s Livmarli Now FDA Approved in Tablet...
FDA Grants Interchangeable Designation to Yuflyma...
About the author
David Miller
a pharmacist, a tech enthusiastic, who explored the Internet to gather all latest information pharma, biotech, healthcare and other related industries.
